These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation]. Urabe A. Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523 [Abstract] [Full Text] [Related]
31. [Chronic myeloid leukemia. State of the art, May 1993]. Hehlmann R. Schweiz Med Wochenschr; 1994 Jan 11; 124(1-2):37-43. PubMed ID: 8296189 [Abstract] [Full Text] [Related]
32. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD. Bone Marrow Transplant; 1991 Dec 11; 8(6):477-87. PubMed ID: 1790428 [Abstract] [Full Text] [Related]
34. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia. Delage R, Ritz J, Anderson KC. Hematol Oncol Clin North Am; 1990 Apr 11; 4(2):369-88. PubMed ID: 2182597 [Abstract] [Full Text] [Related]
35. Unrelated donor and autologous marrow transplant therapy of chronic myelogenous leukemia (CML). McGlave P. Leukemia; 1993 Jul 11; 7(7):1082-3. PubMed ID: 8321029 [Abstract] [Full Text] [Related]
36. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM. J Clin Oncol; 1997 May 11; 15(5):1767-77. PubMed ID: 9164184 [Abstract] [Full Text] [Related]
37. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. Gamis AS, Haake R, McGlave P, Ramsay NK. J Clin Oncol; 1993 May 11; 11(5):834-8. PubMed ID: 8487047 [Abstract] [Full Text] [Related]
38. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK. Zhonghua Zhong Liu Za Zhi; 2006 Jul 11; 28(7):545-8. PubMed ID: 17147125 [Abstract] [Full Text] [Related]
39. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A. Bone Marrow Transplant; 1997 Oct 11; 20(7):553-60. PubMed ID: 9337056 [Abstract] [Full Text] [Related]
40. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J. Bone Marrow Transplant; 1996 May 11; 17(5):685-9. PubMed ID: 8733682 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]